Novosound locks down patent for wearable ultrasound imaging platform
26 Mar 2024
Preview
Source: mobihealthnews
Photo: Hispanolistic/Getty Images
Scottish sensor technology startup Novosound secured a patent for its ultrasound instrumentation system, the Slanj digital platform, which is targeted at the medical and wearables device market.
Novosound produces a wearable, Wi-Fi-enabled ultrasound device that uses gel-free, high-resolution sensors to solve issues associated with traditional ultrasound technology.
The patent gives Novosound exclusive rights to sell its wireless, wearable technology platform in the United States and the United Kingdom.
"I’m really proud that Novosound has obtained the first patent for a wearable ultrasound system. This allows us to integrate and license the technology with smartwatch partners, looking deeper into the body and enhancing the measurements their optical and electrical sensors provide, opening up the holy grail of 24/7 blood pressure monitoring on the wrist," Dave Hughes, CEO and cofounder of Novosound, said in a statement.
THE LARGER TREND
The company was founded in 2018 as the University of the West of Scotland’s first spinoff.
In 2018, Novosound launched with £1.5 million ($1.9 million) in a private equity seed investment.
Novosound received £3.3 million ($4.1 million) in an investment round in 2019, led by Foresight Williams Technology EIS Fund, including additional funding from Foresight Scottish Growth Fund and £1.5 million ($1.9 million) from Par Equity, Kelvin Capital, Gabriel Investments and the Scottish Investment Bank.
The patent for the Slanj digital platform is the 21st awarded to the company since 2018 and is the third patent since 2020 directly related to the company’s wearable ultrasound technology.
In 2020, the British Patent Office awarded Novosound a patent for ultrasound array transducer manufacturing. One year later, the company was awarded another patent for its thin-film ultrasound manufacturing technique.
In 2022, Novosound signed a commercial partnership with diagnostics and digital health company PAVmed Inc. The goal of the partnership was to develop technology to address issues with intravascular imaging.
The company hired former Intel executive David Jolliffe in 2023 and promoted its cofounder David Hughes from chief technology officer to CEO.
Other companies in the ultrasound market include British Columbia-based handheld ultrasound company Clarius Mobile Health and U.S. company Butterfly Network, maker of a handheld, smartphone-connected ultrasound system.
Tags: novosound, app-based ultrasound, imaging, digital health startup, digital health startups, ultrasound, wearables
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.